🔎 Trials Near Me

Beranda › Kanker Kandung Kemih › Georgia › Atlanta

Uji klinis Kanker Kandung Kemih di Atlanta, GA

16 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Atlanta (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Menerima pesertaFase 1
  • Emory University, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Atlanta VA Medical Center, Decatur · 6 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Menerima pesertaFase 2
  • Grady Health System, Atlanta
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • dan 2 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06770582

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Menerima pesertaFase 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Menerima pesertaFase 1
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital, Atlanta
  • Emory University, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07206225

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Menerima pesertaFase 1
  • The Winship Cancer Institute Emory University, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07217171

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Menerima pesertaFase 2
  • Emory University, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06567743

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Menerima pesertaFase 3
  • Urology of Greater Atlanta - Sandy Springs, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Menerima pesertaFase 1
  • Emory University Hospital, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05614739

Measuring Surgical Recovery After Radical Cystectomy

Menerima pesertaStudi observasional
  • Emory University, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Menerima pesertaFase 3
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Menerima pesertaFase 1/2
  • Emory University, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT04752722

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

Menerima pesertaFase 2
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT05756569

Blue Light Cystoscopy With Cysview® Registry

Menerima pesertaStudi observasional
  • Emory University School of Medicine, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Atlanta
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

Menerima pesertaFase 1/2
  • Emory - Winship Cancer Institute, Atlanta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2025 · NCT05086692

Uji klinis Kanker Kandung Kemih di kota lain

Studi lain di Atlanta

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.